Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absorbable Drug-Eluting Lacrimal Sac Stent in Recurrent Chronic Dacryocystitis
NCT07499791Phase 2Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mometasone in dacryocystitis, sponsored by Beijing Tongren Hospital. Started May 2026; status: recruiting.
02
Drugs
mometasone
03
Conditions
dacryocystitis
Beyond the preview
Go deeper on NCT07499791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07499791.